phrykt

International Stem Cell CORP (ISCO): who owns it and who trades it

As of Oct 30, 2026, ISCO insiders reported 1 open-market sale worth $10.5K and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Paul V Maier (Director), with $10.5K.

Latest filing Oct 30, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Insider trades

In the last 12 months, ISCO insiders reported $0 of open-market purchases and $10.5K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$10.5K
1 trades, 1 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Sep 11, 2026
Filed Sep 15, 2026

Purchases and sales by month

$10.5K$10.5KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Sep 11, 2026Paul V MaierDirectorSale32,802$0.32$10.5KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Paul V MaierDirector–$10.5KSep 11, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

ISCO short interest

Low short interest. Less than 0.1% of ISCO shares are sold short. Over the last 12 reports the number of shares short went down 100%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 48 ISCO shares were sold short, 0.0% of the shares outstanding, unchanged from the report before. At the average daily volume of 107,306 shares, buying them all back would take about 1.0 trading days (days to cover).

Shares short, % of all shares

0.00%May 15Oct 300.24%

Days to cover

1.0May 15Oct 30105.4

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026480.00%No change107,3061.0
Oct 15, 2026480.00%No change5,3791.0
Sep 30, 2026480.00%No change30,5891.0
Sep 15, 2026480.00%-94%124,0951.0
Aug 31, 20268080.01%-90%92,0361.0
Aug 14, 20267,8810.10%+345%7,4971.1
Jul 31, 20261,7700.02%+179%58,0001.0
Jul 15, 20266350.01%-91%15,9381.0
Jun 30, 20266,6990.08%-51%7,0531.0
Jun 15, 202613,7050.17%-17%1,4729.3
May 29, 202616,5250.21%-1%18091.8
May 15, 202616,6120.21%+94%4,8123.5

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

International Stem Cell company events

International Stem Cell filed 4 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Sep 8, 2026.

  1. Sep 8, 2026DealAs previously disclosed, on July 10, 2026, International Stem Cell Corporation, a Delaware corporation, International Stem Cell Corporation, a California corporation, Lifeline Cell Technology, LLC, a California limited liability company, and American Type Culture Collection, Inc., a District of… Filing
  2. Jul 16, 2026AgreementInternational Stem Cell Corporation, a Delaware corporation, International Stem Cell Corporation, a California corporation, Lifeline Cell Technology, LLC, a California limited liability company, and American Type Culture Collection, Inc., a District of Columbia corporation, entered into a… Filing
  3. Jun 12, 2026VoteReported shareholder vote results. Filing
  4. Nov 18, 2025VoteReported shareholder vote results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

International Stem Cell financials

Questions about International Stem Cell CORP (ISCO) stock

Are ISCO insiders buying or selling?

In the last 12 months, ISCO insiders reported no open-market purchases and 1 sale worth $10.5K. The latest trade was on Sep 11, 2026. See every trade.

What is the short interest in ISCO?

As of Oct 30, 2026, 48 ISCO shares were sold short, 0.0% of the shares outstanding, unchanged from the report before. At the average daily volume of 107,306 shares, buying them all back would take about 1.0 trading days (days to cover). See the history.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.